Evidence map›Paper›PMID 37125326›Full record

ArticleToxicology research2023

Could the serum glucose/potassium ratio offer an early reliable predictor of life-threatening events in acute methylxanthine intoxication?

Asmaa F Sharif, Zeinab A Kasemy, Heba A Mabrouk, Osama Shoeib, Manar M Fayed

Open access · greenAbstract read
In one paragraph

Article in Toxicology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Asmaa F SharifFaculty of Medicine, Forensic Medicine and Clinical Toxicology Department, Tanta University, Tanta 31527, Egypt.
Zeinab A KasemyFaculty of Medicine, Department of Public Health and Community Medicine, Menoufia University, Shiben Elkom 6132720, Egypt.
Heba A MabroukFaculty of Medicine, Forensic Medicine and Clinical Toxicology Department, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.
Osama ShoeibFaculty of Medicine, Cardiology Department, Tanta University, Tanta 31527, Egypt.
Manar M FayedFaculty of Medicine, Forensic Medicine and Clinical Toxicology Department, Tanta University, Tanta 31527, Egypt.
Tanta University · EGKafrelsheikh University · EGMenoufia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylxanthines are widely used to manage pulmonary disorders, particularly in developing countries. Methylxanthines are unsafe due to their narrow therapeutic index and associated morbidity and mortality. The current study aimed to investigate the role of glucose/potassium ratio as a substantially useful early predictor of life-threatening events (LTEs) in the form of cardiovascular and neurological complications among methylxanthine users. A retrospective cohort study was conducted using medical records of patients diagnosed with acute methylxanthine intoxications and presented to an Egyptian Poison Control Center for 2 years. A total of 366 patients were enrolled. Of them, 59 patients (16.1%) were complicated with LTEs. The most frequent serious arrhythmia was T wave inversion (45.6% of patients with LTEs). Laboratory investigations that could significantly predict LTEs were the random blood glucose and potassium levels, glucose/potassium ratio, pH, liver transaminases, HCO

Indexed as

arrhythmiaglucose/potassium ratiolife threatening eventsmethylxanthineseizurestheophylline

Identifiers

PMID37125326
PMCPMC10141764
OpenAlexW4362211028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.